| Title | Author(s) | Issue date | ???itemlist.??? |
| Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
| Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity | Tselepis, A. D.; Elisaf, M.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Distribution of Paf-Acetylhydrolase Activity in Human Plasma Low-Density-Lipoprotein Subfractions | Karabina, S. A. P.; Liapikos, T. A.; Grekas, G.; Goudevenos, J.; Tselepis, A. D. | 24-Nov-2015 | - |
| Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels | Skrapari, I.; Perrea, D.; Ioannidis, I.; Karabina, S. A. P.; Elisaf, M.; Tselepis, A. D.; Karagiannacos, P.; Katsilambros, N. | 24-Nov-2015 | - |
| High density lipoprotein changes in patients with microvascular angina | Elisaf, M. S.; Karabina, S. A. P.; Tselepis, A. D. | 24-Nov-2015 | - |
| Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia | Karabina, S. A. P.; Elisaf, M.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D. | 24-Nov-2015 | - |
| Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia | Elisaf, M.; Karabina, S. A. P.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D. | 24-Nov-2015 | - |
| The inflammatory state in active juvenile rheumatoid arthritis is associated with hypo HDL-EMIA and reduced lipoprotein-associated PAF-acetylhydrolase activity | Tselepis, A. D.; Elisaf, M. S.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL | Tselepis, A. D.; Karabina, S. A. P.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| PAF-acetylhydrolase activity in familial hypercholesterolaemia | Tselepis, A. D.; Karabina, S. A. P.; Elisaf, M. | 24-Nov-2015 | - |
| PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro | Karabina, S. A. P.; Elisaf, M. C.; Goudevenos, J.; Siamopoulos, K. C.; Sideris, D.; Tselepis, A. D. | 24-Nov-2015 | - |
| Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme | Tselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures | Milionis, H. J.; Elisaf, M. S.; Karabina, S. A. P.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C. | 24-Nov-2015 | - |
| Platelet-Activating-Factor Formation during Oxidative Modification of Low-Density-Lipoprotein When Paf-Acetylhydrolase Has Been Inactivated | Liapikos, T. A.; Antonopoulou, S.; Karabina, S. A. P.; Tsoukatos, D. C.; Demopoulos, C. A.; Tselepis, A. D. | 24-Nov-2015 | - |
| Reduced HDL levels are a major feature of the dyslipidemia characteristic of juvenile chronic arthritis | Tselepis, A. D.; Besis, S.; Elisaf, M.; Karabina, S. A. P.; Lapatsanis, P. D.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetes | Tentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N. | 24-Nov-2015 | - |
